Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › INDGN

INDGN

Indegene Limited
Small-capHealthcare ↗

What the six lenses say about INDGN — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹599.4
2026-09-08
VWAP · 1Y anchor
₹525
+14.1% from VWAP
P/E · TTM
35.9×
TTM EPS ₹16.7
52-week range
93%
position low→high
RSI(14)
68
momentum

Own sector index

Healthcare ↗
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How INDGN’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
6.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD788›

The actual numbers

Price vs VWAP (1y)+14.1%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+13.6%
Price vs 50-EMA+8.4%
RSI(14)68
RS vs Nifty 500 · 3M+12.6%
RS vs sector · 3M+9.9%
52-week range93%
Volume vs 30d avg0.47×
Volume vs 60d avg0.77×
ATR(14) · volatility19.5
Bollinger width · vol contraction0.120
FundamentalD867›

The actual numbers

Return on equity (ROE)14.4%
Return on capital (ROCE)18.8%
Operating margin15.5%
Net margin11.4%
Revenue growth · YoY+23.6%
EPS growth · YoY-2.5%
Debt / equity0.05×

Full 8-quarter history in the financials table below.

ValuationD627›

The actual numbers

P/E (TTM)35.9×
TTM EPS₹16.7
52-week range93%
CatalystD745›

The actual numbers

Earnings & momentum34
Capital actions36
Governance133

Every filing in the corporate-announcements panel below.

FlowD650›

The actual numbers

Promoter holding0.0%
Delivery · 30d avg56.8%
Up/down-day asymmetry0.2pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D7 + D6 ) ÷ 2 = 6.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
84
Conviction score 84/100 · avg-decile strength 6.5/10
Conviction score84/100›
TechnicalD7›
FundamentalD8›
ValuationD6›
CatalystD7›
FlowD6›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.1pp
-0.8pp
+12.4pp
+14.2pp
+33.3pp
+12.3pp
Nifty 500
Broad-market baseline
+0.1pp
-0.8pp
+11.3pp
+12.6pp
+27.5pp
+7.1pp
Sector
Own-sector index
—
—
+10.0pp
+9.9pp
+18.8pp
-6.2pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

INDGN daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
599.35-2.15

Relative strength

RS vs baseline · rebased to 100

INDGN ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
91.21+0.06

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)6776877207567618049421,003
↳ change QoQ—+1.5%+4.9%+4.9%+0.7%+5.7%+17.2%+6.5%
EBITDA (₹cr)151148170148155141160164
EBITDA margin22.4%21.5%23.5%19.6%20.4%17.5%17.0%16.4%
PAT (₹cr)889211011811610210380
↳ change QoQ—+4.6%+19.6%+7.6%-1.7%-12.1%+1.0%-22.3%
Net margin13.0%13.4%15.2%15.6%15.2%12.7%10.9%8.0%
EPS (₹)3.793.844.594.904.854.254.283.31
D/E————————
YoY growth · Mar '26Revenue +32.7% YoYPAT -32.2% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 8 Sep '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 31 Aug '26
    LOWgovernance
    Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 Aug '26
    LOWgovernance
    Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 17 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 17 Aug '26
    MEDIUMgovernance
    Change in Director(s)
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 14 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 31 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Jul '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 30 Jul '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 30 Jul '26
    LOWgovernance
    Monitoring Agency Report
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Jul '26
    LOWgovernance
    Allotment of Securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds INDGN

Mutual funds holding INDGN (10)

FundWeightAUM ₹crGrade
Sundaram Mid Cap Gr0.56%14,504
ICICI Pru Technology Gr0.71%13,540
ICICI Pru Smallcap Instl Gr0.52%9,533
ICICI Pru Smallcap Gr0.52%9,533
Sundaram Agg Hybrid Gr0.58%9,147
Helios Flexi Cap Reg Gr0.58%8,055
SBI Technology Opportunities Reg Gr1.00%4,592
Sundaram Multi Asset Allc Reg Gr0.56%3,314
Sundaram Flexi Cap Reg Gr1.04%1,999
Helios Mid Cap Reg Gr0.63%1,951

ETFs holding INDGN (0)

No tracked ETF holds INDGN ≥0.5%.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare